Filing Details
- Accession Number:
- 0001209191-22-024917
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-20 16:05:37
- Reporting Period:
- 2022-04-19
- Accepted Time:
- 2022-04-20 16:05:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1693011 | Inozyme Pharma Inc. | INZY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579247 | Axel Bolte | C/O Inozyme Pharma, Inc. 321 Summer Street Suite 400 Boston MA 02210 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-19 | 67,750 | $3.69 | 258,575 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
